Note: Ingredients listed on restricted chemical lists
EC/CAS
136-23-2
Name of the chemical
Zinc bis(dibutyldithiocarbamate)
Concentration
N/A
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2019-02-27
Product name
Skin Shield Surgical Gloves
Product Synonyms
Skin Shield Sterile Latex Powder Free Surgical Gloves
1.2.1 Relevant identified uses
Disposable powder-free surgical latex gloves
Icons in SDS
Company Information
company name
LIVINGSTONE INTERNATIONAL PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
sales@livingstone.com.au
Section 2
SECTION 2: Hazards identification
Not classified as hazardous according to NOHSC/ASCC Criteria Not classified as dangerous goods by the criteria of the ADG Code Emergency Overview: This material when properly handled according to good working and hygienic practices is not dangerous to human health and the environment at ambient temperature. General Precautionary Measures: Code
Hazard categories
Conditions for Use P101 If medical advice is needed, have As appropriate N/A Consumer products product container or label at hand. P102 Keep out of reach of children. As appropriate N/A Consumer products P103 Read label before use. As appropriate N/A Consumer products *Note: Natural rubber latex contains a small quantity of natural proteins which may cause an immediate type I hypersensitive reactions such as urticaria and anaphylaxis in a small percentage of the population. However, the process of chlorination to make the gloves powder-free also reduces the extractable protein on the glove surface to below 50μg per gram glove. At such low protein level, sensitization is extremely rare. In any event, a user who cannot tolerate latex gloves is advised to consider alternative nonlatex gloves. Type I hypersensitivity is often accompanied by symptoms such as itching, hives, swelling, runny nose, wheezing and breathing difficulty. Other symptoms may involve nausea, abdominal cramps, increased heart palpitation, decreased blood pressure and anaphylactic shock. Presence of residual ZDBC, ZMBT and anti-oxidants on the product surface may cause delayed type IV hypersensitivity e.g. allergic contact dermatitis and chemical allergy. Reactions include itching, burning sensations, blistering, reddening and pain. In chronic cases, users may develop dry and thickened skin, cracks, peeling and crusting. Inhalation: Unlikely to happen due to product physical appearance. Eye Contact: May cause eye irritation on certain individuals with very sensitive skin. Skin Contact: May cause Type I or IV hypersensitivity on certain individuals with very sensitive skin. Ingestion: Ingestion of harmful amount of this product as distributed may cause nausea or vomiting and can cause damage to digestive system.